Creating Next Generation

Smart Cell Therapies

Outpace is pushing the boundaries of biology to create tailored cell therapy solutions through protein design and custom programming.

 

Our Approach

Outpace is combining the design of improved biological functions and cellular control modalities to harness the full complexity of cellular biology to tackle incurable disease. We create mechanism-driven solutions tailor-made to dramatically improve efficacy and safety.

1/4

The Right Solutions for
the Most Important Problems

We use our unique combination of protein design and cell engineering expertise to solve holy grail problems in cell and gene therapy. We use Rosetta, the most advanced protein design software in the world, to custom design new biological functions. Each solution adds new proteins to our physical platform with generalizable functions that we can repurpose to solve future problems. 

Outpace_tech_chart-22.png
Protein Design Platform
Physical Platform
Solutions
Design new biological functions
Outpace-owned proteins with
generalizable functions
Solutions to holy grail
problems in cell therapy
Outpace_Illustrations_-10.png
Ligand Redesign
Outpace_Illustrations_-11.png
Oligomerization and Orientation
Outpace_Illustrations_-12.png
Outpace_Illustrations_-13.png
Drug-induced Dimerization
Protein Actuator
Logic Gate

Our Platform

Outpace's technologies can modulate diverse biological functions using different control modalities, providing the opportunity to create the optimal solution. Our versatile platform can be applied across multiple problems in diverse areas of biology.

Outpace_Illustrations_09_v4.png
 

Pipeline

Strategic collaborations with world-leading biotechnology and pharmaceutical companies are the cornerstone of the Outpace Business model. In addition to collaboratively developing assets for our partners' portfolios, we are also developing an internal pipeline as the foundation for future development.

 
 

Team

Leadership

Scott Boyken, PhD

CSO

Marc Lajoie, PhD

CEO

Cellular

Control

Glenna Foight, PhD

Ty Crowl

Robin Kirkpatrick, PhD

Leah Tait

Howell Moffett, PhD

AndrewNg.png

Andrew Ng, PhD

Cindy Yang

Custom Biological

Function

Tad Davenport. PhD

Bobby Langan, PhD

Lisa Song

Brian Weitzner, PhD

Syn Bio

Foundry

Emily Bringgold

Kieran Lewis

Aye Chen

Jen Running Deer

Brad Hammerson

Lesley Jones

Board of

Directors

Vasudev Bailey, PhD

Partner, Artis Ventures

Scott Boyken, PhD

CSO, Outpace Bio

Marc Lajoie, PhD

CEO, Outpace Bio

Investors

AV-25-25.png
Logos_Outpace_-29.png
Logos_Outpace_-30.png
Logos_Outpace_-27.png
Logos_Outpace_-34.png
Logos_Outpace_-28.png
Logos_Outpace_-35.png